Articles of the Month
Videos
Articles
Complement-Eosinophil Crosstalk Links Complement Activation to Fibrin Deposition in Eosinophilic Chronic Rhinosinusitis
R.Hasegawa, S.Ueki, M.Arima, et al.Allergy. First published:07 May 2026
MAIT Cells Suppress IgE-Mediated Asthma via IFNγ-Dependent B Cell Regulation
A.M.Cannata, J.W.McAlees, J.M.Hargis, et al.Allergy. First published:07 May 2026
Cost-Effectiveness of Allergen Immunotherapy for Allergic Rhinitis: A Systematic Review
J.Jacob, A.Fong, C.Joyce, et al.Allergy. First published:06 May 2026
Silica Aggravates Steroid Hyporesponsiveness via STING Activation in House Dust Mite Lung Inflammation
B.Mdkhana, N.S.Sharif-Askari, M.W.Eladham, et al.Allergy. First published:06 May 2026
Ultra-Processed Food Consumption and Childhood Allergic Diseases: Increased Risk of Asthma Onset in the SENDO Project
O.Galindo, M.J.Goikoetxea, L.Moreno-Galarraga, et al.Allergy. First published:05 May 2026
Lupus Panniculitis Immunoprofiling Reveals a Cytotoxic, Type 1-Skewed T-Cell Response With Signs of Metabolic Alteration
M.Ameri, R.Ziadlou, S.Traidl, et al.Allergy. First published:05 May 2026
Algorithms in Allergy: Elevated IgE in Pediatric Patients
B.Kolukisa, A.P.S.Arinc, C.Ozdemir, et al.Allergy. First published:04 May 2026
Trace Elements in Allergy: Narrative Review
M.Ordak, M.Zemelka-Wiacek, A.Kosowska, et al.Allergy. First published:04 May 2026
Pollen-Pharmacotherapy Interaction Impacts Symptom Control in Seasonal Allergic Rhinitis
Z.Zhang, M.Wang, X.Wang, et al.Allergy. First published:04 May 2026
Kinetics of Antibody Responses and Effector Cell Sensitivity After High Dose Birch Extract Nasal Challenge
N.J.Campion, S.Villazala-Merino, C.Morgenstern, et al.Allergy. First published:04 May 2026
Algorithms of Patient Selection for Allergen Immunotherapy
U.P.Zieglmayer, S.Arasi, T.Eiwegger, et al.Allergy. First published:02 May 2026
Molecular Characterization of Non-Specific Esophagitis Reveals a Distinct Non-Eosinophilic Phenotype With Fibrotic Traits
M.Pfefferle, D.Stojkov, D.Simon, et al.Allergy. First published:01 May 2026
Treatment Dose Increase Versus Co-Medication in Allergic Rhinitis: Systematic Review With Dose-Response Network Meta-Analysis
B.Sousa-Pinto, R.J.Vieira, S.Gil-Mata, et al.Allergy. First published:01 May 2026
Safety Practices During Hymenoptera Venom Immunotherapy: Single-Centre Experience With Protocolised Intravenous Cannulation and Adrenaline Usage
C.McWaters, N.Weibel, E.Leahy, et al.Allergy. First published:01 May 2026
Geographic and Demographic Trends in Allergen Sensitization: Evidence From a Nationwide Chinese Cohort
H.Gao, L.Ma, Y.Zhao, et al.Allergy. First published:01 May 2026
Determinants of Immunoglobulin-G N-Glycan Patterns in the Aging General Population
S.Leonard, R.Heijmans, V.A.S.H.Dalm, et al.Allergy. First published:30 April 2026
TNF Pathway-Mediated Tolerogenic T-Cell Trajectory Driven by Allergen Immunotherapy
H.S.Charles, A.A.Gabr, S.Wang, et al.Allergy. First published:30 April 2026
IgE Antibody Function and Mast Cell Activation to Egg in Children Undergoing Baked and Loosely Cooked Egg Challenges
V.Houghton, V.Claro, N.Romli, et al.Allergy. First published:29 April 2026
Effects of Live and Heat-Treated Bifidobacterium longumCECT 7347 in Adults With Allergic Rhinitis: A Randomised, Double-Blind, Placebo-Controlled Trial
A.Cardoso, M.Naghibi, E.Climent, et al.Allergy. First published:28 April 2026
Longitudinal Follow-Up of Gut and Salivary Microbiota in Children With Food Protein-Induced Enterocolitis Syndrome
A.Lemoine, K.Adel-Patient, N.Kapel, et al.Allergy. First published:28 April 2026
Definition of Competencies for Allergology Specialty/Subspecialty Training in Mast Cell Disorders in Europe: An EAACI Position Paper
T.A.Rama, T.Gulen, K.Brockow, et al.Allergy. First published:27 April 2026
Resolving Endoplasmic Reticulum-Protein Misfolding Restores Corticosteroid Sensitivity in Experimental Models of Severe Asthma
P.S.Pathinayake, A.C.Brown, N.T.Awatade, et al.Allergy. First published:26 April 2026
Optimising the Diagnosis of Sesame Seed Allergy With the Basophil Activation Test
R.Foong, I.Bartha, H.Boyd, et al.Allergy. First published:26 April 2026
Correspondence: The First Biosimilar for Biologics in Allergy: CT-P39 (Omlyclo-Omalizumab-Igec) Is Available for Asthma, Chronic Spontaneous Urticaria, and Chronic Rhinosinusitis With Nasal Polyps
L.Klimek, J.Mullol, S.Reitsma, et al.Allergy. First published:25 April 2026
Nematode in Cockroaches: A Potential Allergen Source
D.Kang, M.Yi, J.H.Choi, et al.Allergy. First published:24 April 2026
Obituary: Sergio Del Giacco (1936–2026)
S.Bonini, M.J.Torres, M.Shamji, et al.Allergy. First published:23 April 2026
Mast Cells in Acute COVID-19 Patients
I.Zaffran, H.Pahima, E.Ben-Chetrit, et al.Allergy. First published:22 April 2026
Meta-Analysis on the Harm of Systemic Glucocorticosteroids in Inflammatory Upper Airway Disease and Asthma: An EAACI Task Force
S.Scheire, E.Lourijsen, M.Blauwblomme, et al.Allergy. First published:21 April 2026
Retinoic Acid Amplifies IL-4/IL-13–Induced Eotaxin Expression via CRABP1 in Eosinophilic Chronic Rhinosinusitis
H.Yang, Y.Jo, H.Yang, et al.Allergy. First published:21 April 2026
Development of a Comprehensive Allergy Education Program for Primary Care Professionals: An EAACI Initiative
M.Cabrera, D.Ryan, P.Alves, et al.Allergy. First published:19 April 2026
Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts
M.C.Urbano, R.J.Vieira, Y.Xiang, et al.Allergy. First published:18 April 2026
Adrenaline, Anaphylaxis, and Experimental Evidence
J.D.Godsell, J.A.Trubiano.Allergy. First published:18 April 2026
Identification of Shared Regulators of IgE- and MRGPRX2-Dependent Degranulation in Human Mast Cells
J.Folkerts, P.Tienen, M.J.W.Bruijn, et al.Allergy. First published:18 April 2026
Comparative Efficacy of Seven Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Network Meta-Analysis
S.Xu, S.Cai, Y.Zhao, et al.Allergy. First published:18 April 2026
Intestinal STING-(Over)activation—A Contributing Factor to Food Allergies?
S.Goebel, H.R.Schiller.Allergy. First published:18 April 2026
Biphasic Effects on Allergen-Specific Type 2 Memory B Cells Over 18 Months Sublingual Immunotherapy for House Dust Mite Allergy
L.Hsin, S.Reinwald, A.Borstel, et al.Allergy. First published:17 April 2026
Urine Mast Cell Mediator Levels in the Pediatric Population with and without Allergic Disease Stratified by Age and Gender: A Novel Diagnostic Insight
D.V.Manian, J.H.Butterfield, J.W.Meeusen, et al.Allergy. First published:17 April 2026
Differential Effects of Benralizumab and Mepolizumab on Pro-Resolving Mediators
J.Bernaola, J. A.Cañas, Á.Arranz-Fragua, et al.Allergy. First published:17 April 2026
Obituary: Professor Dietrich Kraft (1937-2026)
H.Breiteneder, B.Bohle, K.Hoffmann-Sommergruber, et al.Allergy. First published:16 April 2026
Urticaria and Angioedema: When East Meets West—and the Middle
J.Peter, A.Jindal, S.D.Giacco, et al.Allergy. First published:15 April 2026
Divergent Paths: A Comprehensive Review of Mechanisms and Clinical Implications in Atopic Dermatitis and Psoriasis
T.Czarnowicki, K.Sugita, Z.Yiu, et al.Allergy. First published:15 April 2026
IgE And IgG Antibody Responses to α-Gal and Association With Carotid Stenosis in Swedish Patients
M.Perusko, D.Apostolovic, J.Grundström, et al.Allergy. First published:12 April 2026
Human Rhinovirus A16 Infection of Mast Cells Promotes T2 and Non-T2 Immune Responses That Are Modulated by the Airway Epithelium
Y.Lai, R.C.Murphy, M.Liu, et al.Allergy. First published:12 April 2026
The Dual-Signal Model of Fungal Allergy: Pore-Forming Toxins Prime Epithelial Breach to License Sequential Sensitization
P.Yang, J.Li, Z.Jiang, et al.Allergy. First published:09 April 2026
Citations: 342
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, Aquilina, S, Asero, R, Baker, D, et al. Allergy. 2022; 77: 734– 766
Citations: 147
EAACI guidelines: Anaphylaxis (2021 update)
Muraro A, Worm M, Alviani C, et al. Allergy. 2022; 77: 357–377
Citations: 118
The international WAO/EAACI guideline for the management of hereditary angioedema—The 2021 revision and update
Maurer M, Magerl M, Betschel S, et al. Allergy. 2022; 77: 1961–1990
Citations: 118
The role of peripheral blood eosinophil counts in COVID-19 patients
Xie, G, Ding, F, Han, L, Yin, D, Lu, H, Zhang, M. Allergy. 2021; 76: 471– 482
Citations: 114
Epithelial barrier hypothesis: Effect of the external exposome on the microbiome and epithelial barriers in allergic disease
Celebi Sozener Z, Ozdel Ozturk B, Cerci P, et al. Allergy. 2022; 77: 1418–1449
Citations: 105
Basophil activation test: Mechanisms and considerations for use in clinical trials and clinical practice
Santos, A.F., Alpan, O. and Hoffmann, H.-J. Allergy. 2021; 76: 2420-2432
Citations: 92
Allergenic components of the mRNA-1273 vaccine for COVID-19: Possible involvement of polyethylene glycol and IgG-mediated complement activation
Klimek, L., Novak, N., Cabanillas, B., et al. Allergy. 2021; 76: 3307-3313
Citations: 90
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines
Sokolowska, M., Eiwegger, T., Ollert, M., Torres, M.J., Barber, D., Del Giacco, S., et al. Allergy. 2021; 76: 1629-1639
Citations: 88/h5>
The role of allergen-specific IgE, IgG and IgA in allergic disease
Shamji MH, Valenta R, Jardetzky T, et al. Allergy. 2021; 76: 3627–3641
Citations: 82
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic—An EAACI/ARIA Position Paper
Pfaar, O, Klimek, L, Jutel, M, Akdis, C, A, Bousquet, J, Breiteneder, H, et al. Allergy. 2021; 76: 648– 676
Citations: 81
Advances and highlights in allergic rhinitis
Zhang Y, Lan F, Zhang L. Allergy. 2021; 76: 3383–3389
Citations: 79
Allergic reactions to the first COVID-19 vaccine: A potential role of polyethylene glycol?
Cabanillas, B., Akdis, C.A. and Novak, N. Allergy. 2021; 76: 1617-1618
Citations: 76
Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines
Agache, I., Song, Y., Alonso-Coello, P., Vogel, Y., Rocha, C., Solà, I., et al. Allergy. 2021; 76: 2337-2353
Citations: 74
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Citations: 73
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Allergy. 2022; 77: 812–826
Citations: 70
Vaccines and allergic reactions: The past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., et al. Allergy. 2021; 76: 1640-1660
Citations: 69
Advances and highlights in biomarkers of allergic diseases
Ogulur I, Pat Y, Ardicli O, et al. Allergy. 2021; 76: 3659–3686
Citations: 69
Regulatory B cells, A to Z
Jansen, K., Cevhertas, L., Ma, S., Satitsuksanoa, P., Akdis, M. and van de Veen, W.
Citations: 62
Advances and highlights in asthma in 2021
Agache I, Eguiluz-Gracia I, Cojanu C, et al. Allergy. 2021; 76: 3390–3407
Citations: 62
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Citations: 61
The ingenious mast cell: Contemporary insights into mast cell behavior and function
Dahlin, J.S., Maurer, M., Metcalfe, D.D., Pejler, G., Sagi-Eisenberg, R. and Nilsson, G. Allergy. 2022; 2022; 77: 83-99
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
Zuberbier, T, Abdul Latiff, AH, Abuzakouk, M, et al. Allergy. 2022; 77: 734– 766
The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414
Risk factors for severe and critically ill COVID-19 patients: A review
Gao, Y-D, Ding, M, Dong, X, et al. Allergy. 2021; 76: 428– 455
Vaccines and allergic reactions: the past, the current COVID-19 pandemic, and future perspectives
Sampath, V., Rabinowitz, G., Shah, M., Jain, S., Diamant, Z., Jesenak, M. et al. Allergy. 2021; 76: 1640-1660
Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19
Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581
EAACI guidelines: Anaphylaxis (2021 update)
Muraro, A, Worm, M, Alviani, C, et al. Allergy. 2022; 77: 357– 377
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160
Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741
Advances and recent developments in asthma in 2020
Cevhertas, L, Ogulur, I, Maurer, DJ, et al. Allergy. 2020; 75: 3124– 3146
The international WAO/EAACI guideline for the management of hereditary angioedema – the 2021 revision and update
Maurer, M., Magerl, M., Betschel, S., et al. Allergy. First published: 10 January 2022
A compendium answering 150 questions on COVID-19 and SARS-CoV-2
Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541
Special Issue: Perspectives in Allergen Immunotherapy: 2019 and Beyond
Volume 74 | Issue S108
Management of anaphylaxis due to COVID-19 vaccines in the elderly
Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964
Predictors of treatment response in chronic spontaneous urticaria
Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981
Interleukin-31: The “itchy” cytokine in inflammation and therapy
Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997
Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review
Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016
Eczema herpeticum in atopic dermatitis
Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027
CytoBas: Precision component-resolved diagnostics for allergy using flow cytometric staining of basophils with recombinant allergen tetramers
McKenzie, C.I., Varese, N., Aui, P.M., et al. Allergy. 2021; 76: 3028-3040
Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study
Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052
Direct assessment of individual skin barrier components by electrical impedance spectroscopy
Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106
Prenatal paraben exposure and atopic dermatitis-related outcomes among children
Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132
Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis
Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154
Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy
Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine
Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma
Urbano, A., Plaza, J., Turon, S., et al. Allergy. 2021; 76: 3196-3199
Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202
Identification of Ulocladium chartarum as an important indoor allergen source
Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206
Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis
Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214
Predicted number of peanut-allergic patients needed to treat with epicutaneous immunotherapy (EPIT) to prevent one allergic reaction: A novel approach to assessing relevance
Remington, B.C., Koppelman, S.J., Green, T.D., et al. Allergy. 2021; 76: 3223-3226
Legends of allergy and immunology: Sergio Bonini
Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229
Medical algorithm: Peri-operative management of mastocytosis patients
Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235
Open Access Agreements with Wiley
Check here if your research institution has an agreement with Wiley to make your Original Articles and Review Articles free to read, download and share by everyone: Institutional Payments | Wiley
Junior Members Corner
Dear Junior Members,
Our Junior Member representatives actively participated in the American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting, held in Philadelphia (February 27–March 2). Under the motto “Advancing Precision Medicine from Discovery to Patient Care,” our EAACI JMA representatives had the opportunity to exchange experiences and engage in discussions with AAAAI Fellows-in-Training. This interaction opened the door to new collaborations between our academies, supporting the professional development of our junior members and reinforcing the strong commitment to cooperation between both institutions. In addition, they contributed to increasing EAACI’s visibility at the congress booth and participated in several EAACI organized sessions, including “European Perspective on Immunomodulation in Food Allergy.”
More recently, JMA representatives also provided strong support at the EAACI Spring Meeting, held in Belgrade, Serbia (March 27–29), under the motto “Prevention as Treatment: A New Paradigm.” Alongside an excellent scientific program and presentations from our junior members, the meeting placed a strong emphasis on networking and engagement with national societies from the Balkan region. The goal was to strengthen collaborations, identify unmet needs, and explore synergies to improve the diagnosis, management, and care of patients with allergic diseases.
The collaboration among junior members was a clear example of the value of teamwork and represents an important step forward in strengthening partnerships between national societies within EAACI. This is already driving the development of new educational and scientific initiatives.


Best regards,
The Junior Member Assembly
EAACI Patients Organisation Committee Corner
HIGHLIGHTS FROM PAAM 2025
A group of ten Patient Organisations Committee (POC) members gathered at this wonderful venue in Palau de Congressos de Palma, Mallorca for 2025 Pediatric Allergy and Asthma Focused Meeting. Many had speaker slots giving lived experience perspectives of having children living with allergy and risk of anaphylaxis. So the EAACI PAAM Congress theme of ‘Inspiring insights for every family’ really resonated with us.
As POC, we are with EAACI to help where we can and it brings the science to a person experience, centred level. We had members a wide range of participants from Chile, USA, Turkey, UK, Sweden, Switzerland, France, Italy, Greece and Spain as POC has 36 POC members in 24 countries.
Our Chair, Ozlem Ceylan, gave an overview at the Opening Ceremony on why EAACI awareness campaigns matter, from awareness to action, so patients can feel heard and patient organisations can help lobby for policy change in their country.
POC participated in the Student Awareness Day that was set to educate 40 students aged 14-16 about allergic diseases and emergency response, with the local organising committee’s support.
One of our POC members, Esther Esteban Arroyo opened “The sister society session” with SEICAP and introduced their patient organisation, AEPNAA and their activities in Spain.
Mikaela Odemyr from Swedish Asthma and Allergy Association joined the Anaphylaxis session with a heartfelt talk, “When My Child Had Anaphylaxis: Expectations vs. Reality”. Fallon Schultz from IFPIES USA, gave a wonderful talk on parents’ perspective of dealing with a child’s FPIES journey and introduced their resources to support caregivers. On the last day of PAAM, Maria Zioga from Greece, gave a great talk, “From panic to preparedness: Building trust and resilience in food allergy care” and highlighted the importance of safety for food allergic children.
GA Gallery
<---
